Hide Ya Wives, Hide Ya Kids: Worldwide Coronavirus Pandemic!

Are You Getting The Covid Vaccine?

  • Yes

  • No

  • Only if mandatory

  • Not if mandatory

  • Undecided


Results are only viewable after voting.
The Times found the Gates Foundation endowment had major holdings in:

* Companies ranked among the worst U.S. and Canadian polluters, including ConocoPhillips, Dow Chemical Co. and Tyco International Ltd.

* Many of the world’s other major polluters, including companies that own an oil refinery and one that owns a paper mill, which a study shows sicken children while the foundation tries to save their parents from AIDS.

* Pharmaceutical companies that price drugs beyond the reach of AIDS patients the foundation is trying to treat.

Using the most recent data available, a Times tally showed that hundreds of Gates Foundation investments -- totaling at least $8.7 billion, or 41% of its assets, not including U.S. and foreign government securities -- have been in companies that countered the foundation’s charitable goals or socially concerned philosophy.
 
Might want to think twice about buying/selling on stockx goat etc

FB_IMG_1585310486460.jpg
 
i dont want to derail the thread off a conspiracy theory. But wuhan got 5g first on oct 31st And the symptoms are similar to 5g exposure and that rona always been here look at lysol bottles. They are using rona as a cover up to test 5g equipment.
Please direct all conspiracy theories and questions here...
For a "Valid" response.

Thank you,
Have a blessed day.
 
Last edited:

HALOVAX(TM) ANNOUNCES AGREEMENT WITH HOTH THERAPEUTICS TO JOINT DEVELOP A SELF-ASSEMBLING VACCINE (SAV) TO PROTECT PATIENTS AT RISK OF CORONAVIRUS (COVID-19) INFECTION
THE VACCINE & IMMUNOTHERAPY CENTER (VIC) AT MASSACHUSETTS GENERAL HOSPITAL WILL CONTINUE TO WORK WITH HALOVAX AND HOTH TO ADVANCE THIS PROJECT VOLTRON THERAPEUTICS, INC., THE PARENT OF HALOVAX, HAS AN EXCLUSIVE WORLDWIDE LICENSE TO THE SAV TECHNOLOGY



Humanigen Submits Phase III Protocol Synopsis to FDA for Lenzilumab for Coronavirus Treatment



Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
 
Last edited:

Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

IncellDx’s evaluation of test results from the first four patients suggests immunological benefit within three days following treatment with leronlimab on all four patients and lower level of cytokine storm, especially IL-6 and TNF-α, which were reduced significantly
 
Back
Top Bottom